Prestige Consumer Healthcare Inc. (PBH) Earnings History
Profitable26 years of earnings data (2001–2026) · Positive TTM net income
Loading earnings history...
Prestige Consumer Healthcare Inc. (PBH) Earnings Overview
As of June 22, 2026, Prestige Consumer Healthcare Inc. (PBH) reported trailing twelve-month net income of $190M, reflecting -8.9% year-over-year growth. The company earned $3.99 per diluted share over the past four quarters, with a net profit margin of 17.5%.
Looking at the long-term picture, PBH's 5-year EPS compound annual growth rate (CAGR) stands at +3.8%, reflecting modest earnings expansion. The company achieved its highest annual net income of $340M in fiscal 2018.
Prestige Consumer Healthcare Inc. maintains industry-leading profitability with a gross margin of 52.8%, operating margin of 28.4%, and net margin of 17.5%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including SPB ($126M net income, 3.6% margin), CHD ($733M net income, 11.9% margin), ENR ($195M net income, 8.1% margin), PBH has outperformed on profitability metrics. Compare PBH vs SPB →
PBH Earnings vs Peers
Earnings metrics vs comparable public companies
PBH Historical Earnings Data (2001–2026)
26 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2026 | $190M | -11.3% | $309M | $3.91 | 17.5% | 28.4% |
| 2025 | $215M | +2.5% | $337M | $4.29 | 18.9% | 29.6% |
| 2024 | $209M | +354.3% | $342M | $4.17 | 18.6% | 30.4% |
| 2023 | -$82M | -140.1% | -$22M | $-1.65 | -7.3% | -2.0% |
| 2022 | $205M | +24.7% | $330M | $4.04 | 18.9% | 30.4% |
| 2021 | $165M | +15.7% | $297M | $3.25 | 17.5% | 31.5% |
| 2020 | $142M | +497.4% | $291M | $2.78 | 14.8% | 30.2% |
| 2019 | -$36M | -110.5% | $68M | $-0.69 | -3.7% | 6.9% |
| 2018 | $340M | +389.3% | $216M | $6.34 | 32.6% | 20.7% |
| 2017 | $69M | -30.5% | $206M | $1.30 | 7.9% | 23.3% |
| 2016 | $100M | +27.7% | $260M | $1.88 | 12.4% | 32.3% |
| 2015 | $78M | +7.8% | $208M | $1.49 | 11.0% | 29.0% |
| 2014 | $73M | +10.9% | $189M | $1.39 | 12.1% | 31.3% |
| 2013 | $66M | +76.0% | $192M | $1.27 | 10.5% | 30.8% |
| 2012 | $37M | +27.4% | $103M | $0.73 | 8.4% | 23.3% |
| 2011 | $29M | -9.0% | $76M | $0.58 | 8.7% | 22.6% |
| 2010 | $32M | +117.2% | $79M | $0.64 | 10.6% | 26.1% |
| 2009 | -$187M | -650.7% | -$168M | $-3.74 | -59.7% | -53.6% |
| 2008 | $34M | -6.0% | $91M | $0.68 | 10.4% | 28.0% |
| 2007 | $36M | +37.3% | $95M | $0.72 | 11.3% | 29.7% |
| 2006 | $26M | +95.2% | $84M | $0.53 | 8.9% | 28.3% |
| 2005 | $13M | +221.8% | $94M | $-0.55 | 4.4% | 30.8% |
| 2004 | $4M | +128.1% | $17M | $0.02 | 4.8% | 19.1% |
| 2003 | -$15M | -2833.2% | $27M | $-0.30 | -20.8% | 38.2% |
| 2002 | $545,000 | -78.4% | $15M | $-0.55 | 1.2% | 32.3% |
| 2001 | $3M | - | $5M | $0.10 | 29.2% | 56.3% |
Download Data
Export PBH earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
25+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PBH — Frequently Asked Questions
Quick answers to the most common questions about buying PBH stock.
What is PBH earnings per share (EPS)?
PBH trailing twelve-month (TTM) diluted EPS is $3.99, reflecting -8.9% year-over-year growth. The 5-year EPS CAGR is +3.8%. Complete EPS history from 2001 to 2026 is available in the table on this page.
What is Prestige Consumer Healthcare Inc.'s net income?
Prestige Consumer Healthcare Inc. (PBH) trailing twelve-month net income is $190M as of 2026. Earnings declined -8.9% year-over-year. Prestige Consumer Healthcare Inc. has been profitable for 3 consecutive years.
Is PBH profitable?
Yes, PBH is profitable with a TTM net income of $190M and a net profit margin of +17.5%. Prestige Consumer Healthcare Inc. has generated profits for 3 consecutive years.
What is PBH's earnings growth rate?
PBH compound annual EPS growth rates (CAGR): 1-Year: -8.9%, 3-Year: N/A, 5-Year: +3.8%, 10-Year: +7.6%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2001 to 2026.
What are PBH's profit margins?
Prestige Consumer Healthcare Inc. net profit margin is +17.5%, operating margin is +28.4%, and gross margin is +52.8%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +10.2%.
Is PBH growing earnings?
PBH earnings are declining — EPS fell -8.9% year-over-year. TTM net income dropped to $190M. This contrasts with the 5-year CAGR of +3.8%.
What was PBH's best earnings year?
Prestige Consumer Healthcare Inc.'s highest annual net income on record is $340M, achieved in fiscal year 2018. Earnings history on this page spans 2001 to 2026 and includes all annual and quarterly figures.
What were PBH's earnings last quarter?
PBH's most recent reported quarter was Q4 2026. Net income was $54M with diluted EPS of $1.13. For a full breakdown of all quarters, see the quarterly earnings table on this page.